Calamos Advisors
MR

Calamos Advisors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Calamos Advisors’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-127,000
Closed -$4.94M – 670
2013
Q3 		$4.94M Hold
127,000
– – 0.03% 301
2013
Q2 		$4.76M Buy
+127,000
New +$5.01M 0.03% 294

Other funds holding MR

CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Calamos Advisors's MR Position: Q4 2013 in Review

Calamos Advisors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q4 2013, closing a stake of 127,000 shares — an estimated $4.94M sold.

Calamos Advisors first reported a position in MR in Q2 2013 and held it in 2 quarters. The position peaked at $4.94M in Q3 2013. 165 funds tracked by Wall St. Rank hold MR as of Q4 2013.

  • Calamos Advisors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q4 2013 after selling out during the quarter.
  • Calamos Advisors sold 127,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q4 2013, an estimated $4.94M.
  • Calamos Advisors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 2 quarters.
  • Calamos Advisors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $4.94M in Q3 2013.
  • 165 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q4 2013.

Based on Calamos Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.